Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Graft-versus-host Disease

Sicca symptoms and their impact on quality of life among very long-term survivors after hematopoietic SCT

Abstract

The objective of this prospective cross-sectional case-control study was to examine the prevalence of dryness symptoms and its impact on quality of life (QoL) among very long-term survivors after hematopoietic SCT (HSCT) in comparison with their respective sibling donors. Forty-four allogeneic HSCT recipients with a long-term survival (median: 17.5; range: 11–26 years) were included. Their respective, HLA-identical sibling donors served as controls. Clinical examinations included saliva flow rates (SFR) and the Schirmer's test. The presence of sicca symptoms of mouth, eyes and skin were inquired. The social functioning (SF)-36 questionnaire was applied. Recipients had lower (P<0.01) unstimulated and stimulated mean SFR than donors. Schirmer’s test results <5 mm was found in 45% of the recipients in comparison with 27% of the donors (P=0.07). Xerostomia (34 vs 4 subjects), xerophtalmia (23 vs 3) and dry skin (32 vs 12) were reported more often by the recipients than donors (P<0.001). Sicca symptoms and their objective findings correlated with QoL. The mean SF-36 scores of the donors were significantly higher than those of the recipients for physical component summary. In conclusion, sicca symptoms are common amongst long-term survivors of HSCT and affect remarkably the QoL.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Appelbaum FR . Hematopoietic-cell transplantation at 50. N Engl J Med 2007; 357: 1472–1475.

    Article  CAS  Google Scholar 

  2. Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 2007; 110: 3784–3792.

    Article  CAS  Google Scholar 

  3. Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A et al. Hematopoietic stem cell transplantation: a global perspective. J Am Dent Assoc 2010; 303: 1617–1624.

    Article  CAS  Google Scholar 

  4. Hong CH, Napenas JJ, Hodgson BD, Stokman MA, Mathers-Stauffer V, Elting LS et al. A systematic review of dental disease in patients undergoing cancer therapy. Support Care Cancer 2010; 18: 1007–1021.

    Article  Google Scholar 

  5. Lalla RV, Latortue MC, Hong CH, Ariyawardana A, D'Amato-Palumbo S, Fischer DJ et al. A systematic review of oral fungal infections in patients receiving cancer therapy. Support Care Cancer 2010; 18: 985–992.

    Article  Google Scholar 

  6. Sreebny LM . Saliva in health and disease: an appraisal and update. Int Dent J 2000; 50: 140–161.

    Article  CAS  Google Scholar 

  7. Tichelli A, Duell T, Weiss M, Socie G, Ljungman P, Cohen A et al. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects. Bone Marrow Transplant 1996; 17: 1105–1111.

    CAS  PubMed  Google Scholar 

  8. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer 2010; 18: 1039–1060.

    Article  CAS  Google Scholar 

  9. Laaksonen M, Ramseier AM, Rovo A, Jensen SB, Raber-Durlacher JE, Zitzmann NU et al. Longitudinal assessment of hematopoietic stem cell transplantation and hyposalivation. J Dent Res 2011; 90: 1177–1182.

    Article  CAS  Google Scholar 

  10. Hull KM, Kerridge I, Schifter M . Long-term oral complications of allogeneic haematopoietic SCT. Bone Marrow Transplant 2012; 47: 265–270.

    Article  CAS  Google Scholar 

  11. Imanguli MM, Atkinson JC, Mitchell SA, Avila DN, Bishop RJ, Cowen EW et al. Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation. Biol Blood Marrow Transplant 2010; 16: 1362–1369.

    Article  Google Scholar 

  12. Nagler R, Marmary Y, Krausz Y, Chisin R, Markitziu A, Nagler A . Major salivary gland dysfunction in human acute and chronic graft-versus-host disease (GVHD). Bone Marrow Transplant 1996; 17: 219–224.

    CAS  Google Scholar 

  13. Westeneng AC, Hettinga Y, Lokhorst H, Verdonck L, van Dorp S, Rothova A . Ocular graft-versus-host disease after allogeneic stem cell transplantation. Cornea 2010; 29: 758–763.

    Article  Google Scholar 

  14. Dykewicz CA . Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients. Clin Infect Dis 2001; 33: 139–144.

    Article  CAS  Google Scholar 

  15. Jancel T, Penzak SR . Antiviral therapy in patients with hematologic malignancies, transplantation, and aplastic anemia. Semin Hematol 2009; 46: 230–247.

    Article  CAS  Google Scholar 

  16. Maertens J, Frère P, Lass-Flörl C, Heinz W, Cornely OA . Primary antifungal prophylaxis in leukaemia patients. Eur J Cancer Suppl. 2007; 5: 43–48.

    Article  CAS  Google Scholar 

  17. Kincaid MC, Green WR . Ocular and orbital involvement in leukemia. Surv Ophthalmol. 1983; 27: 211–232.

    Article  CAS  Google Scholar 

  18. Gedikoglu G, Altinoz MA . Differentiation-inducing liposoluble vitamin deficiency may explain frequent secondary solid tumors after hematopoietic stem cell transplantation: minireview. Neoplasma 2008; 55: 1–9.

    CAS  PubMed  Google Scholar 

  19. McDiarmid S . Nutritional support of the patient receiving high-dose therapy with hematopoietic stem cell support. Can Oncol Nurs J 2002; 12: 102–115.

    Article  Google Scholar 

  20. Duell T, van Lint MT, Ljungman P, Tichelli A, Socie G, Apperley JF et al. Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med 1997; 126: 184–192.

    Article  CAS  Google Scholar 

  21. Wingard JR, Curbow B, Baker F, Piantadosi S . Health, functional status, and employment of adult survivors of bone marrow transplantation. Ann Intern Med 1991; 114: 113–118.

    Article  CAS  Google Scholar 

  22. Lopez-Jornet P, Camacho-Alonso F . Quality of life in patients with Sjögren’s syndrome and sicca complex. J Oral Rehabil 2008; 35: 875–881.

    Article  CAS  Google Scholar 

  23. Rovo A, Daikeler T, Halter J, Heim D, Tsakiris DA, Stern M et al. Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor. Haematologica 2011; 96: 150–155.

    Article  Google Scholar 

  24. Baerlocher GM, Rovo A, Muller A, Matthey S, Stern M, Halter J et al. Cellular senescence of white blood cells in very long-term survivors after allogeneic hematopoietic stem cell transplantation: the role of chronic graft-versus-host disease and female donor sex. Blood 2009; 114: 219–222.

    Article  CAS  Google Scholar 

  25. Rovo A, Daikeler T, Stern M, Halter J, Studt JD, Buser A et al. Physical and not mental health is impaired in very long-term survivors after HSCT compared with their respective donors: a paired analysis. Blood 2008; 111: 1740–1741.

    Article  CAS  Google Scholar 

  26. Ware JE Jr, Sherbourne CD . The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473–483.

    Article  Google Scholar 

  27. McHorney CA, Ware JE Jr, Raczek AE . The MOS 36-Item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247–263.

    Article  CAS  Google Scholar 

  28. Ware JE, Kosinski M, Keller SD . SF-36 Physical And Mental Health Summary Scales: A User’s Manual. New England Medical Center, The Health Institute: Boston, MA, 1994.

    Google Scholar 

  29. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554–558.

    Article  CAS  Google Scholar 

  30. Vissink A, Jansma J, Spijkervet FK, Burlage FR, Coppes RP . Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 2003; 14: 199–212.

    Article  CAS  Google Scholar 

  31. Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA . Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999; 45: 577–587.

    Article  CAS  Google Scholar 

  32. Shannon IL, Trodahl JN, Starcke EN . Radiosensitivity of the human parotid gland. Proc Soc Exp Biol Med 1978; 157: 50–53.

    Article  CAS  Google Scholar 

  33. Vissink A, Mitchell JB, Baum BJ, Limesand KH, Jensen SB, Fox PC et al. Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers. Int J Radiat Oncol Biol Phys 2010; 78: 983–991.

    Article  Google Scholar 

  34. Chaushu G, Itzkovitz-Chaushu S, Yefenof E, Slavin S, Or R, Garfunkel AA . A longitudinal follow-up of salivary secretion in bone marrow transplant patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 79: 164–169.

    Article  CAS  Google Scholar 

  35. Dahllöf G, Bagesund M, Ringden O . Impact of conditioning regimens on salivary function, caries-associated microorganisms and dental caries in children after bone marrow transplantation. A 4-year longitudinal study. Bone Marrow Transplant 1997; 20: 479–483.

    Article  Google Scholar 

  36. Jones LR, Toth BB, Keene HJ . Effects of total body irradiation on salivary gland function and caries-associated oral microflora in bone marrow transplant patients. Oral Surg Oral Med Oral Pathol 1992; 73: 670–676.

    Article  CAS  Google Scholar 

  37. Buchali A, Feyer P, Groll J, Massenkeil G, Arnold R, Budach V . Immediate toxicity during fractionated total body irradiation as conditioning for bone marrow transplantation. Radiother Oncol 2000; 54: 157–162.

    Article  CAS  Google Scholar 

  38. Majhail NS, Ness KK, Burns LJ, Sun CL, Carter A, Francisco L et al. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Biol Blood Marrow Transplant 2007; 13: 1153–1159.

    Article  Google Scholar 

  39. Kosrirukvongs P, Chirapapaisan N, Visuthisakchai S, Issaragrisil S, Gonggetyai V . Sjogren-like syndrome after bone marrow transplantation. J Med Assoc Thai 2008; 91: 1739–1747.

    PubMed  Google Scholar 

  40. Ogawa Y, Okamoto S, Wakui M, Watanabe R, Yamada M, Yoshino M et al. Dry eye after haematopoietic stem cell transplantation. Br J Ophthalmol 1999; 83: 1125–1130.

    Article  CAS  Google Scholar 

  41. Tichelli A, Gratwohl A, Egger T, Roth J, Prunte A, Nissen C et al. Cataract formation after bone marrow transplantation. Ann Intern Med 1993; 119: 1175–1180.

    Article  CAS  Google Scholar 

  42. Esteban JM, Somlo G . Skin biopsy in allogeneic and autologous bone marrow transplant patients: a histologic and immunohistochemical study and review of the literature. Mod Pathol 1995; 8: 59–64.

    CAS  PubMed  Google Scholar 

  43. Kim SJ, Choi JM, Kim JE, Cho BK, Kim DW, Park HJ . Clinicopathologic characteristics of cutaneous chronic graft-versus-host diseases: a retrospective study in Korean patients. Int J Dermatol 2010; 49: 1386–1392.

    Article  Google Scholar 

  44. Champey J, Corruble E, Gottenberg JE, Buhl C, Meyer T, Caudmont C et al. Quality of life and psychological status in patients with primary Sjogren’s syndrome and sicca symptoms without autoimmune features. Arthritis Rheum 2006; 55: 451–457.

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by the Swiss National Science Foundation (Nr 3200B0-118176), the Horten Foundation and the Werner Geissberger Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T Waltimo.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Daikeler, T., Mauramo, M., Rovó, A. et al. Sicca symptoms and their impact on quality of life among very long-term survivors after hematopoietic SCT. Bone Marrow Transplant 48, 988–993 (2013). https://doi.org/10.1038/bmt.2012.260

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2012.260

Keywords

This article is cited by

Search

Quick links